83_FR_62807 83 FR 62574 - Relocation Allowances: Taxes on Travel, Transportation, and Relocation Expenses

83 FR 62574 - Relocation Allowances: Taxes on Travel, Transportation, and Relocation Expenses

GENERAL SERVICES ADMINISTRATION

Federal Register Volume 83, Issue 233 (December 4, 2018)

Page Range62574-62575
FR Document2018-26342

The purpose of this notice is to inform Federal agencies that FTR Bulletin 19-02, pertaining to travel, transportation, and relocation allowances impacted by recent changes to Federal tax law, has been published and is now available online at www.gsa.gov/ ftrbulletin.

Federal Register, Volume 83 Issue 233 (Tuesday, December 4, 2018) 
[Federal Register Volume 83, Number 233 (Tuesday, December 4, 2018)]
[Notices]
[Pages 62574-62575]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-26342]


=======================================================================
-----------------------------------------------------------------------

GENERAL SERVICES ADMINISTRATION

[Notice-MA-2018-10; Docket No. 2018-0002; Sequence No. 28]


Relocation Allowances: Taxes on Travel, Transportation, and 
Relocation Expenses

AGENCY: Office of Government-wide Policy (OGP), General Services 
Administration (GSA).

[[Page 62575]]


ACTION: Notice of Federal Travel Regulation (FTR) Bulletin 19-02, 
Relocation Allowances--Taxes on Travel, Transportation, and Relocation 
Expenses.

-----------------------------------------------------------------------

SUMMARY: The purpose of this notice is to inform Federal agencies that 
FTR Bulletin 19-02, pertaining to travel, transportation, and 
relocation allowances impacted by recent changes to Federal tax law, 
has been published and is now available online at www.gsa.gov/ftrbulletin.

DATES: Applicability: This notice applies to travel, transportation, 
and relocation expenses paid on or after January 1, 2018.

FOR FURTHER INFORMATION CONTACT: For clarification of content, please 
contact Mr. Rick Miller, Office of Government-wide Policy, Office of 
Asset and Transportation Management, at 202-501-3822, or by email at 
[email protected]. Please cite Notice of FTR Bulletin 19-02.

    Dated: November 27, 2018.
Jessica Salmoiraghi,
Associate Administrator, Office of Government-wide Policy.
[FR Doc. 2018-26342 Filed 12-3-18; 8:45 am]
BILLING CODE 6820-14-P

62574 Federal Register / Vol. 83, No. 233 / Tuesday, December 4, 2018 / Notices TABLE 1—REGISTRATION REVIEW INTERIM DECISIONS BEING ISSUED—Continued Docket ID num- Registration review case name and number Chemical review manager and contact information ber Dried Fermentation Solids and Solubles of Myrothecium EPA–HQ–OPP– Cody Kendrick, kendrick.cody@epa.gov, (703) 347–0468 verrucaria, Case 6051. 2013–0539. EPTC, Case 0064 ..................................................................... EPA–HQ–OPP– Patricia Biggio, biggio.patricia@epa.gov, (703) 347–0547 2012–0720. Ethylene, Case 3071 ................................................................. EPA–HQ–OPP– Susanne Cerrelli, cerrelli.susanne@epa.gov, (703) 308–8077 2009–0877. Fludioxonil, Case 7017 .............................................................. EPA–HQ–OPP– Patricia Biggio, biggio.patricia@epa.gov, (703) 347–0547 2010–1067. Formic Acid, Case 6073 ............................................................ EPA–HQ–OPP– Cody Kendrick, kendrick.cody@epa.gov, (703) 347–0468 2014–0105. Methyl Nonyl Ketone, Case 3094 ............................................. EPA–HQ–OPP– Daniel Schoeff, schoeff.daniel@epa.gov, (703) 347–0143 2012–0125. Niclosamide, Case 2455 ........................................................... EPA–HQ–OPP– R. David Jones, jones.rdavid@epa.gov, (703) 305–6725 2013–0137. N6-Benzyladenine, Case 2040 .................................................. EPA–HQ–OPP– Alexandra Boukedes, boukedes.alexandra@epa.gov, (703) 2011–0190. 347–0305 Potassium Silicate, Case 6204 ................................................. EPA–HQ–OPP– Donna Kamarei, kamarei.donna@epa.gov, (703) 347–0443 2017–0329. Propamocarb hydrochloride, Case 3124 .................................. EPA–HQ–OPP– Christina Scheltema, scheltema.christina@epa.gov, (703) 2011–0662. 308–2201 Putrescent Whole Egg Solids, Case 4079 ................................ EPA–HQ–OPP– Susanne Cerrelli, cerrelli.susanne@epa.gov, (703) 308–8077 2010–0726. Sodium carbonate, Case 4066 ................................................. EPA–HQ–OPP– SanYvette Williams, williams.sanyvette@epa.gov, (703) 305– 2012–0809. 7702 TFM, Case 3082 ....................................................................... EPA–HQ–OPP– R. David Jones, jones.rdavid@epa.gov, (703) 305–6725 2013–0137. The proposed interim registration FEDERAL RESERVE SYSTEM Unless otherwise noted, comments review decisions for the chemicals in regarding each of these applications the table above were posted to the Formations of, Acquisitions by, and must be received at the Reserve Bank docket and the public was invited to Mergers of Bank Holding Companies indicated or the offices of the Board of submit any comments or new Governors not later than December 31, information. EPA addressed the The companies listed in this notice 2018. comments or information received have applied to the Board for approval, A. Federal Reserve Bank of Atlanta during the 60-day comment period for pursuant to the Bank Holding Company (Kathryn Haney, Assistant Vice the proposed interim decisions in the Act of 1956 (12 U.S.C. 1841 et seq.) President) 1000 Peachtree Street NE, discussion for each pesticide listed in (BHC Act), Regulation Y (12 CFR part Atlanta, Georgia 30309. Comments can the table. Comments from the 60-day 225), and all other applicable statutes also be sent electronically to comment period that were received may and regulations to become a bank Applications.Comments@atl.frb.org: or may not have affected the Agency’s holding company and/or to acquire the 1. B.P.C. Corporation, Cookeville, interim decision. Pursuant to 40 CFR assets or the ownership of, control of, or Tennessee; to merge with CFB 155.58(c), the registration review case the power to vote shares of a bank or Bancshares, Inc., and thereby indirectly docket for the chemicals listed in the bank holding company and all of the acquire Citizens First Bank, both of Table will remain open until all actions banks and nonbanking companies Wartburg, Tennessee. required in the interim decision have owned by the bank holding company, Board of Governors of the Federal Reserve been completed. including the companies listed below. System, November 29, 2018. This document also announces the The applications listed below, as well Yao-Chin Chao, closure of the registration review case as other related filings required by the Assistant Secretary of the Board. for Bis (bromoacetoxy)-2-butene (BBAB) Board, are available for immediate [FR Doc. 2018–26328 Filed 12–3–18; 8:45 am] (Case 3030, Docket ID Number EPA– inspection at the Federal Reserve Bank BILLING CODE P HQ–OPP–2014–0799), because the last indicated. The applications will also be U.S. registrations for these pesticides available for inspection at the offices of have been canceled. Background on the the Board of Governors. Interested GENERAL SERVICES registration review program is provided persons may express their views in ADMINISTRATION at: http://www.epa.gov/pesticide- writing on the standards enumerated in reevaluation. the BHC Act (12 U.S.C. 1842(c)). If the [Notice–MA–2018–10; Docket No. 2018– proposal also involves the acquisition of 0002; Sequence No. 28] Authority: 7 U.S.C. 136 et seq. a nonbanking company, the review also Dated: October 25, 2018. Relocation Allowances: Taxes on includes whether the acquisition of the Yu-Ting Guilaran, Travel, Transportation, and Relocation nonbanking company complies with the Director, Pesticide Re-Evaluation Division, Expenses standards in section 4 of the BHC Act Office of Pesticide Programs. (12 U.S.C. 1843). Unless otherwise AGENCY: Office of Government-wide [FR Doc. 2018–26354 Filed 12–3–18; 8:45 am] noted, nonbanking activities will be Policy (OGP), General Services BILLING CODE 6560–50–P conducted throughout the United States. Administration (GSA). VerDate Sep<11>2014 17:36 Dec 03, 2018 Jkt 247001 PO 00000 Frm 00015 Fmt 4703 Sfmt 4703 E:\FR\FM\04DEN1.SGM 04DEN1

Federal Register / Vol. 83, No. 233 / Tuesday, December 4, 2018 / Notices 62575 ACTION: Notice of Federal Travel Mailing Address: Center for Evidence enrolled/lost to follow-up/withdrawn/ Regulation (FTR) Bulletin 19–02, and Practice Improvement, Agency for analyzed, effectiveness/efficacy, and Relocation Allowances—Taxes on Healthcare Research and Quality, safety results. Travel, Transportation, and Relocation ATTN: EPC SEADs Coordinator, 5600 D A list of ongoing studies that your Expenses. Fishers Lane, Mail Stop 06E53A, organization has sponsored for this Rockville, MD 20857. indication. In the list, please provide the SUMMARY: The purpose of this notice is Shipping Address (FedEx, UPS, etc.): ClinicalTrials.gov trial number or, if the to inform Federal agencies that FTR Center for Evidence and Practice trial is not registered, the protocol for Bulletin 19–02, pertaining to travel, Improvement, Agency for Healthcare the study including a study number, the transportation, and relocation Research and Quality, ATTN: EPC study period, design, methodology, allowances impacted by recent changes SEADs Coordinator, 5600 Fishers Lane, indication and diagnosis, proper use to Federal tax law, has been published Mail Stop 06E77D, Rockville, MD instructions, inclusion and exclusion and is now available online at 20857. criteria, and primary and secondary www.gsa.gov/ftrbulletin. outcomes. FOR FURTHER INFORMATION CONTACT: DATES: Applicability: This notice applies Jenae Benns, Telephone: 301–427–1496 D Description of whether the above to travel, transportation, and relocation or Email: epc@ahrq.hhs.gov. studies constitute ALL Phase II and expenses paid on or after January 1, above clinical trials sponsored by your SUPPLEMENTARY INFORMATION: The 2018. organization for this indication and an Agency for Healthcare Research and index outlining the relevant information FOR FURTHER INFORMATION CONTACT: For Quality has commissioned the clarification of content, please contact in each submitted file. Evidence-based Practice Centers (EPC) Your contribution will be very Mr. Rick Miller, Office of Government- Program to complete a review of the wide Policy, Office of Asset and beneficial to the EPC Program. Materials evidence for Interventions for Substance submitted must be publicly available or Transportation Management, at 202– Use Disorders in Adolescents: A 501–3822, or by email at travelpolicy@ able to be made public. Materials that Systematic Review. AHRQ is conducting are considered confidential; marketing gsa.gov. Please cite Notice of FTR this systematic review pursuant to Bulletin 19–02. materials; study types not included in Section 902(a) of the Public Health the review; or information on Dated: November 27, 2018. Service Act, 42 U.S.C. 299a(a). indications not included in the review Jessica Salmoiraghi, The EPC Program is dedicated to cannot be used by the EPC Program. Associate Administrator, Office of identifying as many studies as possible This is a voluntary request for Government-wide Policy. that are relevant to the questions for information, and all costs for complying [FR Doc. 2018–26342 Filed 12–3–18; 8:45 am] each of its reviews. In order to do so, we with this request must be borne by the are supplementing the usual manual submitter. BILLING CODE 6820–14–P and electronic database searches of the The draft of this review will be posted literature by requesting information on AHRQ’s EPC Program website and from the public (e.g., details of studies available for public comment for a DEPARTMENT OF HEALTH AND conducted). We are looking for studies period of 4 weeks. If you would like to HUMAN SERVICES that report on Interventions for be notified when the draft is posted, Agency for Healthcare Research and Substance Use Disorders in please sign up for the email list at: Quality Adolescents: A Systematic Review, https:// including those that describe adverse www.effectivehealthcare.ahrq.gov/ Supplemental Evidence and Data events. The entire research protocol, email-updates. Request on Interventions for including the key questions, is also The systematic review will answer the Substance Use Disorders in available online at: https:// following questions. This information is Adolescents: A Systematic Review effectivehealthcare.ahrq.gov/topics/ provided as background. AHRQ is not substance-use-disorders-adolescents/ requesting that the public provide AGENCY: Agency for Healthcare Research protocol. and Quality (AHRQ), HHS. answers to these questions. This is to notify the public that the ACTION: Request for supplemental EPC Program would find the following The Key Questions evidence and data submissions. information on Interventions for KQ 1: What are the effects of Substance Use Disorders in behavioral, pharmacologic, and SUMMARY: The Agency for Healthcare Adolescents: A Systematic Review combined interventions compared with Research and Quality (AHRQ) is seeking helpful: placebo or no active treatment for scientific information submissions from D A list of completed studies that substance use disorders and problematic the public. Scientific information is your organization has sponsored for this substance use 1 in adolescents to being solicited to inform our review of indication. In the list, please indicate Interventions for Substance Use achieve abstinence, reduce quantity and whether results are available on frequency of use, improve functional Disorders in Adolescents: A Systematic ClinicalTrials.gov along with the Review, which is currently being outcomes, and reduce substance-related ClinicalTrials.gov trial number. harms? conducted by the AHRQ’s Evidence- D For completed studies that do not a. How do benefits and adverse based Practice Centers (EPC) Program. have results on ClinicalTrials.gov, outcomes of interventions vary by Access to published and unpublished please provide a summary, including subpopulations? 2 pertinent scientific information will the following elements: study number, improve the quality of this review. study period, design, methodology, 1 Substances considered: Alcohol, cannabis, DATES: Submission Deadline on or indication and diagnosis, proper use opioids, sedatives/hypnotics/anxiolytics, before January 3, 2019. instructions, inclusion and exclusion stimulants, inhalants and hallucinogens. Tobacco is excluded. ADDRESSES: Email submissions: epc@ criteria, primary and secondary 2 Subpopulations considered: Psychiatric co- ahrq.hhs.gov. outcomes, baseline characteristics, morbidities, age (early, middle and late Print submissions: number of patients screened/eligible/ Continued VerDate Sep<11>2014 17:36 Dec 03, 2018 Jkt 247001 PO 00000 Frm 00016 Fmt 4703 Sfmt 4703 E:\FR\FM\04DEN1.SGM 04DEN1


Document Created: 2018-12-04 00:42:38
Document Modified: 2018-12-04 00:42:38
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of Federal Travel Regulation (FTR) Bulletin 19-02, Relocation Allowances--Taxes on Travel, Transportation, and Relocation Expenses.
DatesApplicability: This notice applies to travel, transportation, and relocation expenses paid on or after January 1, 2018.
ContactFor clarification of content, please contact Mr. Rick Miller, Office of Government-wide Policy, Office of Asset and Transportation Management, at 202-501-3822, or by email at [email protected] Please cite Notice of FTR Bulletin 19-02.
FR Citation83 FR 62574 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR